revlimid (lenalidomide) maintenance therapy approved for multiple myeloma patients
Published 7 years ago • 6.7K plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
1:51
why roswell park for multiple myeloma?
-
4:37
dr. philip mccarthy discusses roswell park comprehensive cancer center's clinical trials for myeloma
-
0:59
our blood donation guidelines are changing! 🎉🩸
-
1:57
what is the survival rate for multiple myeloma?
-
2:24
myeloma: lenalidomide maintenance therapy
-
1:30
the impact of lenalidomide maintenance therapy on myeloma patients in the uk
-
1:57
what is the best treatment for multiple myeloma?
-
17:13
all about revlimid (lenalidomide)
-
3:48
abecma car t-cell therapy for multiple myeloma
-
1:05:27
myeloma crowd radio: dr. philip mccarthy, roswell park cancer institute
-
1:07
toxicities associated with lenalidomide for multiple myeloma
-
4:22
future maintenance therapy approaches for multiple myeloma
-
3:05
imaging for multiple myeloma
-
1:33
safety of lenalidomide maintenance therapy in myeloma patients following transplantation
-
1:08
dr. philip mccarthy on lenalidomide maintenance for multiple myeloma
-
59:49
using revlimid as a successful treatment for myeloma patients with kidney involvement
-
1:07
lenalidomide as a highly-effective maintenance therapy in myeloma
-
5:31
post-transplant lenalidomide maintenance for myeloma
-
2:21
lenalidomide maintenance therapy in patients with multiple myeloma and high-risk cytogenetics